Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer

This study has been terminated.
(The study did not achieve the statistical success to continue.)
Sponsor:
Collaborator:
Millennium Pharmaceuticals, Inc.
Information provided by:
Montefiore Medical Center
ClinicalTrials.gov Identifier:
NCT00200382
First received: September 13, 2005
Last updated: December 7, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2007
  Estimated Primary Completion Date: No date given